Annual Retained Earnings
-$186.29 M
-$30.09 M-19.27%
December 31, 2023
Summary
- As of February 7, 2025, ATOS annual retained earnings is -$186.29 million, with the most recent change of -$30.09 million (-19.27%) on December 31, 2023.
- During the last 3 years, ATOS annual retained earnings has fallen by -$74.39 million (-66.48%).
- ATOS annual retained earnings is now -15298.25% below its all-time high of -$1.21 million, reached on December 31, 2010.
Performance
ATOS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$205.44 M
-$7.23 M-3.65%
September 30, 2024
Summary
- As of February 7, 2025, ATOS quarterly retained earnings is -$205.44 million, with the most recent change of -$7.23 million (-3.65%) on September 30, 2024.
- Over the past year, ATOS quarterly retained earnings has dropped by -$26.91 million (-15.07%).
- ATOS quarterly retained earnings is now -53290.07% below its all-time high of -$384.80 thousand, reached on June 30, 2010.
Performance
ATOS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ATOS Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.3% | -15.1% |
| 3 y3 years | -66.5% | -65.2% |
| 5 y5 years | -142.5% | -65.2% |
ATOS Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.1% | at low | -59.0% | at low |
| 5 y | 5-year | -98.0% | at low | -118.4% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Atossa Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$205.44 M(+3.6%) |
| Jun 2024 | - | -$198.22 M(+3.1%) |
| Mar 2024 | - | -$192.17 M(+3.2%) |
| Dec 2023 | -$186.29 M(+19.3%) | -$186.29 M(+4.3%) |
| Sep 2023 | - | -$178.53 M(+3.6%) |
| Jun 2023 | - | -$172.31 M(+6.1%) |
| Mar 2023 | - | -$162.47 M(+4.0%) |
| Dec 2022 | -$156.19 M(+20.9%) | -$156.19 M(+5.0%) |
| Sep 2022 | - | -$148.70 M(+5.7%) |
| Jun 2022 | - | -$140.69 M(+5.0%) |
| Mar 2022 | - | -$134.02 M(+3.7%) |
| Dec 2021 | -$129.23 M(+15.5%) | -$129.23 M(+3.9%) |
| Sep 2021 | - | -$124.40 M(+4.4%) |
| Jun 2021 | - | -$119.20 M(+6.3%) |
| Mar 2021 | - | -$112.17 M(+0.2%) |
| Dec 2020 | -$111.90 M(+19.0%) | -$111.90 M(+7.2%) |
| Sep 2020 | - | -$104.42 M(+3.5%) |
| Jun 2020 | - | -$100.92 M(+4.0%) |
| Mar 2020 | - | -$97.02 M(+3.1%) |
| Dec 2019 | -$94.07 M(+22.4%) | -$94.07 M(+2.9%) |
| Sep 2019 | - | -$91.45 M(+3.7%) |
| Jun 2019 | - | -$88.17 M(+9.0%) |
| Mar 2019 | - | -$80.90 M(+5.3%) |
| Dec 2018 | -$76.83 M(+17.4%) | -$76.83 M(+2.8%) |
| Sep 2018 | - | -$74.75 M(+4.6%) |
| Jun 2018 | - | -$71.44 M(+6.2%) |
| Mar 2018 | - | -$67.30 M(+2.9%) |
| Dec 2017 | -$65.43 M | -$65.43 M(+3.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | -$63.43 M(+3.6%) |
| Jun 2017 | - | -$61.25 M(+3.8%) |
| Mar 2017 | - | -$59.01 M(+3.0%) |
| Dec 2016 | -$57.30 M(+12.5%) | -$57.30 M(+4.6%) |
| Sep 2016 | - | -$54.78 M(-0.4%) |
| Jun 2016 | - | -$54.98 M(+3.2%) |
| Mar 2016 | - | -$53.26 M(+4.6%) |
| Dec 2015 | -$50.93 M(+44.8%) | -$50.93 M(+10.8%) |
| Sep 2015 | - | -$45.97 M(+10.4%) |
| Jun 2015 | - | -$41.66 M(+8.2%) |
| Mar 2015 | - | -$38.51 M(+9.5%) |
| Dec 2014 | -$35.17 M(+71.4%) | -$35.17 M(+19.8%) |
| Sep 2014 | - | -$29.36 M(+12.4%) |
| Jun 2014 | - | -$26.12 M(+13.9%) |
| Mar 2014 | - | -$22.93 M(+11.8%) |
| Dec 2013 | -$20.52 M(+110.8%) | -$20.52 M(+15.5%) |
| Sep 2013 | - | -$17.76 M(+24.6%) |
| Jun 2013 | - | -$14.26 M(+22.1%) |
| Mar 2013 | - | -$11.67 M(+19.9%) |
| Dec 2012 | -$9.73 M(+109.2%) | -$9.73 M(+21.3%) |
| Sep 2012 | - | -$8.03 M(+16.6%) |
| Jun 2012 | - | -$6.88 M(+20.4%) |
| Mar 2012 | - | -$5.71 M(+22.8%) |
| Dec 2011 | -$4.65 M(+284.5%) | -$4.65 M(+35.0%) |
| Sep 2011 | - | -$3.45 M(+184.9%) |
| Dec 2010 | -$1.21 M | -$1.21 M(+39.5%) |
| Sep 2010 | - | -$867.20 K(+125.4%) |
| Jun 2010 | - | -$384.80 K |
FAQ
- What is Atossa Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Atossa Therapeutics?
- What is Atossa Therapeutics annual retained earnings year-on-year change?
- What is Atossa Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Atossa Therapeutics?
- What is Atossa Therapeutics quarterly retained earnings year-on-year change?
What is Atossa Therapeutics annual retained earnings?
The current annual retained earnings of ATOS is -$186.29 M
What is the all time high annual retained earnings for Atossa Therapeutics?
Atossa Therapeutics all-time high annual retained earnings is -$1.21 M
What is Atossa Therapeutics annual retained earnings year-on-year change?
Over the past year, ATOS annual retained earnings has changed by -$30.09 M (-19.27%)
What is Atossa Therapeutics quarterly retained earnings?
The current quarterly retained earnings of ATOS is -$205.44 M
What is the all time high quarterly retained earnings for Atossa Therapeutics?
Atossa Therapeutics all-time high quarterly retained earnings is -$384.80 K
What is Atossa Therapeutics quarterly retained earnings year-on-year change?
Over the past year, ATOS quarterly retained earnings has changed by -$26.91 M (-15.07%)